One vs. two doses of 1.0% apraclonidine for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
Sunnybrook Health Science Centre, University of Toronto, Ont.
C M
CM
Birt
D H
DH
Shin
S Y
SY
Reed
B
B
McCarty
C
C
Kim
R E
RE
Frenkel
D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003000:Clonidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D053685:Laser Therapy / Q000009:adverse effects; D008297:Male; D009798:Ocular Hypertension / Q000188:drug therapy* / Q000209:etiology; D011446:Prospective Studies; D014130:Trabeculectomy / Q000009:adverse effects
D000959:Antihypertensive Agents; C016986:apraclonidine; D003000:Clonidine